Table 5.
Association between diagnostic delay and surgery in CD patients.
| Factors | Unadjusted hazard ratio [95% CI]a | p-value | Adjusted hazard ratio [95% CI] | p-value |
|---|---|---|---|---|
| Diagnostic delayb | 1.01 [0.60–1.70] | 0.97 | 0.93 [0.55–1.59] | 0.80 |
| Male | 0.92 [0.59–1.46] | 0.74 | 0.90 [0.57–1.44] | 0.67 |
| Age at diagnosis [years] | 1.04 [0.96–1.12] | 0.38 | 1.02 [0.94–1.11] | 0.55 |
| Distal ileal ± caecal [L1] | 1.74 [1.05–2.88] | 0.032 | 1.71 [1.03–2.86] | 0.040 |
| Upfront anti-TNF use2 | 1.35 [0.77–2.38] | 0.30 | 1.37 [0.77–2.42] | 0.28 |
CD, Crohn’s disease; TNF, tumour necrosis factor; CI, confidence nterval; HR, hazard ratio.
aHR >1 indicates faster time to diagnosis; HR <1 indicates slower time to diagnosis.
bTime to diagnosis >75th percentile in CD subgroup [10.8 months].
cAs first therapy.